DWTX · NASDAQ · Biotechnology

Dogwood Therapeutics (DWTX)

Develops non-opioid therapies for chemotherapy-related neuropathic pain.

$2.47
Pre-market−0.01 (−0.40%)
At close$2.48(−5.70%)

Something off on this page? Send us feedback.

Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.15
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$4.21−$1.99−$8.20−$0.26−$0.15−$0.34−$0.34Pending
Estimate−$0.77−$1.26−$1.23−$0.86−$0.22−$0.13−$0.14−$0.15
Surprise−446.8%−57.9%−566.7%+69.8%+31.8%−161.5%−142.9%

RevenueReportedEstimate

May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
ReportedPending
Estimate
Surprise

History

DateEstimateReportedSurprise
Nov 2026−$0.15
Aug 2026−$0.14−$0.34−142.9%
Aug 2026−$0.13−$0.34−161.5%
May 2026−$0.22−$0.15+31.8%
Mar 2026−$0.86−$0.26+69.8%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Nov 2025
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Sep 2022
Jun 2022
Mar 2022
Dec 2021
Sep 2021
Jun 2021
Mar 2021
Dec 2020
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 5, 2026−$0.15
Aug 13, 2026−$0.14−$0.34−142.9%+2.6%
Aug 12, 2026−$0.13−$0.34−161.5%+4.9%
May 14, 2026−$0.22−$0.15+31.8%−7.6%
Mar 18, 2026−$0.86−$0.26+69.8%−8.4%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Nov 6, 2025
Aug 13, 2025
May 8, 2025
Feb 26, 2025
Nov 7, 2024
Aug 8, 2024
May 9, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019